Literature DB >> 8199402

Disappearance of polycystic kidney disease in revertant c-myc transgenic mice.

M Trudel1, N Chrétien, V D'Agati.   

Abstract

Nineteen SBM transgenic mouse lines specifically expressing the c-myc protooncogene in renal epithelium Transgene expression is completely penetrant, leading to death from renal failure. In the course of continuous breeding of eight transgenic lines, all lines underwent spontaneous transgene mutations characterized by partial deletion and probable rearrangement of the transgene insert. Revertant mice and their progeny have no evidence of renal disease. This constitutes the first report of spontaneous mutations occurring within transgene inserts. The high spontaneous mutation frequency of 10(-2) to 10(-3) greatly exceeds that of naturally occurring mutations and is probably favored by the transgene's multiple tandem insertion. These spontaneous mutations demonstrate that the intact transgene is necessary and sufficient to produce the SBM phenotype. Further, these results implicate deregulation of factor(s) governing epithelial cell proliferation in the pathogenesis of PKD in SBM mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8199402     DOI: 10.1007/bf00352345

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  13 in total

1.  Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40.

Authors:  K MacKay; L J Striker; C A Pinkert; R L Brinster; G E Striker
Journal:  Kidney Int       Date:  1987-12       Impact factor: 10.612

Review 2.  Homologous recombination in mammalian cells.

Authors:  R J Bollag; A S Waldman; R M Liskay
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

3.  Homologous recombination between coinjected DNA sequences peaks in early to mid-S phase.

Authors:  E A Wong; M R Capecchi
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

4.  Sequence-specific DNA binding by the c-Myc protein.

Authors:  T K Blackwell; L Kretzner; E M Blackwood; R N Eisenman; H Weintraub
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

5.  Linkage heterogeneity of autosomal dominant polycystic kidney disease.

Authors:  W J Kimberling; P R Fain; J B Kenyon; D Goldgar; E Sujansky; P A Gabow
Journal:  N Engl J Med       Date:  1988-10-06       Impact factor: 91.245

6.  Renal cyst formation and multifocal neoplasia in transgenic mice carrying the simian virus 40 early region.

Authors:  K A Kelley; N Agarwal; S Reeders; K Herrup
Journal:  J Am Soc Nephrol       Date:  1991-07       Impact factor: 10.121

7.  Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse.

Authors:  B D Cowley; L J Chadwick; J J Grantham; J P Calvet
Journal:  J Am Soc Nephrol       Date:  1991-02       Impact factor: 10.121

8.  Analysis of the integrant in MyK-103 transgenic mice in which males fail to transmit the integrant.

Authors:  T M Wilkie; R D Palmiter
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

9.  A second genetic locus for autosomal dominant polycystic kidney disease.

Authors:  G Romeo; M Devoto; G Costa; L Roncuzzi; L Catizone; P Zucchelli; G G Germino; T Keith; D J Weatherall; S T Reeders
Journal:  Lancet       Date:  1988-07-02       Impact factor: 79.321

10.  A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16.

Authors:  S T Reeders; M H Breuning; K E Davies; R D Nicholls; A P Jarman; D R Higgs; P L Pearson; D J Weatherall
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

View more
  6 in total

Review 1.  Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease.

Authors:  Carsten Bergmann; Valeska Frank; Fabian Küpper; Dirk Kamitz; Jens Hanten; Peter Berges; Silke Mager; Markus Moser; Jutta Kirfel; Reinhard Büttner; Jan Senderek; Klaus Zerres
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

2.  Generation of c-Myc transgenic pigs for autosomal dominant polycystic kidney disease.

Authors:  Jianhua Ye; Jin He; Qiuyan Li; Yuanyuan Feng; Xueyuan Bai; Xiangmei Chen; Yaofeng Zhao; Xiaoxiang Hu; Zhengquan Yu; Ning Li
Journal:  Transgenic Res       Date:  2013-03-30       Impact factor: 2.788

3.  C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.

Authors:  M Trudel; J Lanoix; L Barisoni; M J Blouin; M Desforges; C L'Italien; V D'Agati
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

4.  Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression.

Authors:  M Trudel; L Barisoni; J Lanoix; V D'Agati
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

5.  Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice.

Authors:  L Barisoni; M Trudel; N Chrétien; L Ward; J van Adelsberg; V D'Agati
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

6.  Cystin genetic variants cause autosomal recessive polycystic kidney disease associated with altered Myc expression.

Authors:  Chaozhe Yang; Naoe Harafuji; Amber K O'Connor; Robert A Kesterson; Jacob A Watts; Amar J Majmundar; Daniela A Braun; Monkol Lek; Kristen M Laricchia; Hanan M Fathy; Shrikant Mane; Shirlee Shril; Friedhelm Hildebrandt; Lisa M Guay-Woodford
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.